Companion Diagnostic Biomarkers: Importance, Trend, and Forecast

A companion diagnostic is a predictive biomarker test, utilized to support dosing decision-making for patient stratification and treatment. It received global support and the market size is expected to double within the next 5 years. This webinar reviews the importance and regulatory success of companion diagnostic biomarker assays in currently approved drugs, as well as forecasting the trend and possible issues that might arise in the future. In addition, the outsourcing of companion diagnostic tests to a contract research lab will be discussed.

Resource Preview